Screening for Scleroderma

The purpose of screening is early diagnosis and treatment. Screening tests are usually administered to people without current symptoms, but who may be at high risk for certain diseases or conditions.

At this time, there are no screening tests or screening guidelines for scleroderma.

References

Feldman M, et al. Sleisenger & Fordtran's Gastrointestinal and Liver Disease . 8th ed. St. Louis, MO: Mosby; 2005.

Ferri F ed. Ferri’s Clinical Advisor 2011 . 1st ed. Philadelphia, PA: Mosby Elsevier; 2010.

Firestein ED et al. Kelley’s Textbook of Rheumatology . 8th ed. Philadelphia, PA: Saunders; 2008.

Goldman L, Ausiello D, eds. Cecil Textbook of Internal Medicine . 23rd ed. Philadelphia, PA: Saunders; 2008.

Habif TP. Clinical Dermatology . 4th ed. St. Louis, MO: Mosby; 2004.

Harrison’s Principles of Internal Medicine . 15th ed. McGraw Hill; 2001.

National Institute of Arthritis and Musculoskeletal and Skin Diseases website. Available at: http://www.niams.nih.gov/ .

Noble J. Textbook of Primary Care Medicine . 3rd ed. St. Louis, MO: Mosby; 2000.

Rakel R. Textbook of Family Medicine 2007. 7th ed. Philadelphia, PA: Saunders Elsevier; 2009.

Rakel RE, Bope ET. Conn's Current Therapy . 60th ed. Philadelphia, PA: Saunders Elsevier; 2009.

Scleroderma Foundation website. Available at: http://www.scleroderma.org/ .

Revision Information

Reviewer: Rosalyn Carson-DeWitt, MD
Review Date: 12/2011
Update Date: 12/30/2011

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.